Speaker illustration

Doctor Markus Riederer

Idorsia Pharmaceuticals, Allschwil (Switzerland)

Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Thrombosis, Bleeding

Session: Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction

Thumbnail

This platform is supported by

logo Novo Nordisk